Drug intelligence / Profile preview

GPR110 siRNA

Development stage: Unknown
Lead developer: Santa Cruz Biotechnology
Modality: Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration: Parenteral

Overview

GPR110 siRNA is a research-grade small interfering RNA (siRNA) reagent designed to knock down the expression of the GPR110 (ADGRF1) gene, which encodes an adhesion G protein-coupled receptor. It is primarily used as a laboratory tool in preclinical research to investigate the biological roles of GPR110. Studies have utilized GPR110 siRNA to explore its involvement in HER2-positive breast cancer tumorigenesis, metastasis, and drug resistance, as well as in metabolic-associated steatohepatitis (MASH) mouse models.

Other names: ADGRF1 siRNAADGRF-1 siRNAADGRF 1 siRNAGPR110 small interfering RNAGPR-110 small interfering RNAGPR 110 small interfering RNAGpr110 siRNAGpr-110 siRNAGpr 110 siRNA

Targets

ADGRF1

Beyond the preview

Go deeper on GPR110 siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GPR110 siRNA.

Explore the full profile